ZURICH — Roche’s newly acquired subsidiary TIB Molbiol has developed three new tests kits to detect mutations present in the new COVID-19 Omicron variant, Roche said on Friday. Read More
Roche Develops New Test Kits for COVID-19 Omicron Variant

Find out what people like and dislike about your competitors, and compare it with your brand performance.